Special Issue "New Trends in the Controlled Release Systems of Medicinal Substances Used in the Treatment of Diseases of the Central Nervous System"
Deadline for manuscript submissions: 20 December 2023 | Viewed by 2958
Interests: biomaterials; biomedical engineering; drug technology; surface sciences
Special Issues, Collections and Topics in MDPI journals
This Special Issue is dedicated to advances in innovative drug delivery systems used in the treatment of central nervous system diseases, i.e., schizophrenia, bipolar affective disorder, depression, dementia, neurodegenerative disorders such as Parkinson’s or Alzheimer’s disease, and brain tumors with special attention to glioblastoma multiforme.
The SI targets the aspect of the delivery of medicinal substances, administration of medicinal products, permeation through the blood–brain barrier, ensuring therapeutic concentration, and the formulation process.
The topics of interest include the following areas:
- Design and formulation methods of drug delivery systems to brain tissue administration;
- The mechanisms of drug delivery, drug release patterns, and in vitro–in vivo correlation;
- Nanoscale brain-targeting drug delivery strategies overcoming the blood–brain barrier;
- Intracranial drug delivery systems as an independent therapeutic procedure or supporting surgical methods;
- Current state orally disintegrating tablets used in neurodegenerative diseases;
- The role of multiple-coated and multi-content formulations in therapy optimization.
I hope that this Special Issue will provide a roadmap for all scientists and practitioners in the treatment of central nervous system diseases.
Dr. Artur Turek
Dr. Zhenjia Wang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery systems
- brain-targeting drug delivery
- central nervous system
- Parkinson’s disease
- Alzheimer’s disease
- glioblastoma multiforme